| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |